+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Real-Time PCR Devices Market - Global Forecast 2026-2032- Product Image
Real-Time PCR Devices Market - Global Forecast 2026-2032- Product Image
Sale

Real-Time PCR Devices Market - Global Forecast 2026-2032

  • Report

  • 198 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6159587
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Real-Time PCR Devices Market is projected to reach USD 2.08 Billion in 2026. It is expected to continue growing at a CAGR of 6.84%, reaching USD 3.09 Billion by 2032.

Real-Time PCR Devices: Executive Summary

Real-time PCR devices enable the rapid amplification and quantification of nucleic acids for clinical diagnostics, life-science research, food testing, environmental monitoring, and public-health surveillance. Their value proposition centers on sensitive detection, quantitative results, workflow automation, and compatibility with increasingly integrated molecular-testing systems. Demand is shaped by infectious-disease preparedness, decentralized testing, genomic research, laboratory modernization, and the need for reproducible results across diverse sample types.

How Molecular Testing Is Becoming Faster, More Connected, and More Flexible

The landscape is shifting from stand-alone instruments toward connected workflows that combine extraction, amplification, detection, analysis, and reporting. Laboratories increasingly prioritize shorter turnaround times, simplified operation, multiplexing, contamination control, and flexible throughput. Procurement decisions are also influenced by interoperability with laboratory information systems, service support, consumable availability, regulatory requirements, and total workflow reliability rather than instrument specifications alone.

Artificial Intelligence Is Strengthening Interpretation and Laboratory Operations

Artificial intelligence is contributing to real-time PCR workflows through automated quality checks, anomaly detection, threshold and curve interpretation, assay optimization, and predictive maintenance. Machine-learning tools can help identify irregular amplification patterns and support more consistent review of complex results, while natural-language interfaces may simplify instrument operation and reporting. Adoption remains dependent on validated algorithms, traceable decision logic, cybersecurity, data governance, and appropriate human oversight, particularly in regulated diagnostic settings.

Regional Dynamics Reflect Uneven Infrastructure and Testing Priorities

North America benefits from established molecular-testing infrastructure, strong research capacity, and sustained attention to public-health preparedness. Europe emphasizes laboratory quality, regulatory compliance, interoperability, and cross-border surveillance, while Asia-Pacific combines expanding healthcare access with substantial research, manufacturing, and infectious-disease monitoring activity. Latin America is shaped by uneven laboratory distribution, procurement constraints, and the need for scalable decentralized testing. The Middle East is investing in advanced healthcare and specialized laboratories, whereas Africa continues to prioritize accessible diagnostics, workforce development, resilient supply chains, and deployment models suited to variable infrastructure.

Economic and Institutional Groups Shape Procurement and Collaboration

ASEAN countries are linked by regional disease-surveillance needs, varied laboratory maturity, and growing interest in accessible molecular workflows. BRICS members reflect a combination of large patient populations, domestic research capacity, and efforts to strengthen local diagnostic resilience. The European Union places emphasis on harmonized standards, cross-border health data, and coordinated surveillance. G7 members generally combine advanced research ecosystems with demanding quality and cybersecurity expectations. GCC countries are expanding sophisticated healthcare infrastructure and centralized laboratory capabilities, while NATO members place additional importance on preparedness, interoperability, and continuity of critical diagnostic operations.

Country-Level Priorities Range from Research Leadership to Access Expansion

Australia emphasizes geographically adaptable testing and strong laboratory quality systems. Brazil and Mexico continue to address regional disparities and public-health surveillance needs. Canada and the United States combine advanced clinical, academic, and biotechnology applications with rigorous oversight. China and India are expanding domestic diagnostic capacity, research activity, and supply-chain resilience. France, Germany, Italy, Spain, and the United Kingdom prioritize regulated laboratory performance, infectious-disease monitoring, and research integration. Japan and South Korea emphasize automation, precision, and high-quality laboratory workflows, while Russia’s landscape is influenced by domestic capability, public-health requirements, and procurement resilience.

Priorities for Leaders: Build Reliable, Interoperable, and Scalable Workflows

Industry leaders should evaluate instruments as part of complete testing workflows rather than as isolated platforms. Priorities include validated multiplex assays, intuitive software, robust quality controls, open data connectivity, cybersecurity, dependable service networks, and consumable continuity. Organizations should match throughput and automation to actual workload, establish evidence-based validation procedures, and train personnel in interpretation and troubleshooting. Partnerships with public-health agencies, reference laboratories, research institutions, and local distributors can improve deployment resilience, particularly where infrastructure and technical expertise vary. AI features should be adopted incrementally with documented performance, auditability, and human review.

Research Methodology: Evidence-Led Assessment of the Device Landscape

This executive summary applies a structured qualitative assessment of real-time PCR devices across applications, workflow requirements, technology trends, regulatory considerations, and geographic operating conditions. The analysis distinguishes instrument capabilities from broader laboratory adoption factors and integrates regional, economic-group, and country-level context. Insights are framed around observable drivers such as infectious-disease preparedness, laboratory modernization, research activity, automation, connectivity, and supply-chain resilience. No market estimates, market shares, forecasts, or company-specific claims are used.

Conclusion: Real-Time PCR Devices Remain Central to Modern Molecular Testing

Real-time PCR devices remain important because they combine quantitative molecular detection with adaptable laboratory workflows across clinical, research, food, environmental, and public-health settings. Competitive differentiation increasingly depends on reliability, workflow integration, usability, data quality, and support infrastructure. As laboratories pursue faster and more distributed testing, successful adoption will favor solutions that pair validated analytical performance with interoperable software, responsible AI, resilient supply chains, and deployment models aligned with local needs.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Real-Time PCR Devices Market, by Product Type
7.1. Introduction
7.2. Instruments
7.2.1. High Throughput Instruments
7.2.2. Low Throughput Instruments
7.2.3. Medium Throughput Instruments
7.3. Reagents Kits
7.3.1. Consumables Kits
7.3.2. Custom Assay Kits
7.3.3. Master Mixes
7.4. Software And Services
7.4.1. Services
7.4.2. Software
8. Real-Time PCR Devices Market, by Technology
8.1. Introduction
8.2. Molecular Beacons
8.3. Probe-Based Chemistry
8.4. Scorpion Probes
8.5. SYBR Green Chemistry
9. Real-Time PCR Devices Market, by Throughput
9.1. Introduction
9.2. High Throughput
9.3. Low Throughput
9.4. Medium Throughput
10. Real-Time PCR Devices Market, by Application
10.1. Introduction
10.2. Agriculture Biotechnology
10.3. Disease Diagnostics
10.3.1. Genetic Testing
10.3.1.1. Hereditary Disorders
10.3.1.2. Pharmacogenomics
10.3.2. Infectious Disease
10.3.2.1. Bacterial Infection
10.3.2.2. Parasitic Infection
10.3.2.3. Viral Infection
10.3.3. Oncology Diagnostics
10.3.3.1. Liquid Biopsy
10.3.3.2. Solid Tumor Detection
10.4. Drug Discovery
10.5. Environmental Testing
10.6. Food And Beverage Testing
10.7. Forensic Testing
10.8. Gene Expression Analysis
10.9. Oncology Research
11. Real-Time PCR Devices Market, by End User
11.1. Introduction
11.2. Academic Research Institutes
11.3. Clinical Laboratories
11.4. Contract Research Organizations
11.5. Environmental Testing Laboratories
11.6. Food And Beverage Testing Laboratories
11.7. Pharmaceutical And Biotech Companies
11.8. Veterinary Laboratories
12. Real-Time PCR Devices Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Real-Time PCR Devices Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Real-Time PCR Devices Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abcam plc
16.2. Agilent Technologies, Inc.
16.3. Analytik Jena AG
16.4. Becton Dickinson and Company
16.5. Bio Molecular Systems Pty Ltd.
16.6. Bio-Rad Laboratories, Inc.
16.7. BioFire Diagnostics, LLC
16.8. Eppendorf AG
16.9. Hologic, Inc.
16.10. Illumina, Inc.
16.11. Lumiprobe Corporation
16.12. Mesa Biotech, Inc.
16.13. Promega Corporation
16.14. Qiagen GmbH
16.15. QIAGEN N.V.
16.16. Roche Diagnostics International AG
16.17. SGI-DNA, LLC
16.18. Stilla Technologies SA
16.19. Takara Bio Inc.
16.20. Thermo Fisher Scientific Inc.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Real-Time PCR Devices Market, Years Considered for the Study
FIGURE 2. Global Real-Time PCR Devices Market, Research Design
FIGURE 3. Global Real-Time PCR Devices Market, Research Framework
FIGURE 4. Global Real-Time PCR Devices Market, Data Triangulation
FIGURE 5. Global Real-Time PCR Devices Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Real-Time PCR Devices Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Real-Time PCR Devices Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Real-Time PCR Devices Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Real-Time PCR Devices Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Real-Time PCR Devices Market Size, by Throughput, 2025 vs 2032 (%)
FIGURE 11. Global Real-Time PCR Devices Market Size, by Throughput, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Real-Time PCR Devices Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Real-Time PCR Devices Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Real-Time PCR Devices Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Real-Time PCR Devices Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Real-Time PCR Devices Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Real-Time PCR Devices Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Real-Time PCR Devices Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Real-Time PCR Devices Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Real-Time PCR Devices Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Real-Time PCR Devices Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Real-Time PCR Devices Market Segmentation & Coverage
TABLE 2. Global Real-Time PCR Devices Market Size, 2017-2032 (USD Million)
TABLE 3. Global Real-Time PCR Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global High Throughput Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global High Throughput Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global High Throughput Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Low Throughput Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Low Throughput Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Low Throughput Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Medium Throughput Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Medium Throughput Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Medium Throughput Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Reagents Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Reagents Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Reagents Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Consumables Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Consumables Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Consumables Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Custom Assay Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Custom Assay Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Custom Assay Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Master Mixes Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Master Mixes Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Master Mixes Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Software And Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Software And Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Software And Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Real-Time PCR Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 38. Global Molecular Beacons Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Molecular Beacons Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Molecular Beacons Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Probe-Based Chemistry Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Probe-Based Chemistry Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Probe-Based Chemistry Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Scorpion Probes Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Scorpion Probes Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Scorpion Probes Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global SYBR Green Chemistry Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global SYBR Green Chemistry Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global SYBR Green Chemistry Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Real-Time PCR Devices Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 51. Global High Throughput Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global High Throughput Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global High Throughput Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Low Throughput Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Low Throughput Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Low Throughput Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Medium Throughput Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Medium Throughput Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Medium Throughput Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Real-Time PCR Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 61. Global Agriculture Biotechnology Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Agriculture Biotechnology Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Agriculture Biotechnology Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Disease Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Disease Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Disease Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Genetic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Genetic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Genetic Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Hereditary Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Hereditary Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Hereditary Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Pharmacogenomics Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Pharmacogenomics Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Pharmacogenomics Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Infectious Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Infectious Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Infectious Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Bacterial Infection Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Bacterial Infection Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Bacterial Infection Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Parasitic Infection Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Parasitic Infection Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Parasitic Infection Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Viral Infection Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Viral Infection Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Viral Infection Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Oncology Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Oncology Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Oncology Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Liquid Biopsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Liquid Biopsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Liquid Biopsy Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Solid Tumor Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Solid Tumor Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Solid Tumor Detection Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Drug Discovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Drug Discovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Drug Discovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Environmental Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Environmental Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Environmental Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Food And Beverage Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Food And Beverage Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Food And Beverage Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Forensic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Forensic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Forensic Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Gene Expression Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Gene Expression Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Gene Expression Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Oncology Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Oncology Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Oncology Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Real-Time PCR Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 116. Global Academic Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Global Academic Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. Global Academic Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. Global Clinical Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Global Clinical Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. Global Clinical Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 125. Global Environmental Testing Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Global Environmental Testing Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. Global Environmental Testing Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 128. Global Food And Beverage Testing Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 129. Global Food And Beverage Testing Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. Global Food And Beverage Testing Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 131. Global Pharmaceutical And Biotech Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 132. Global Pharmaceutical And Biotech Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. Global Pharmaceutical And Biotech Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 134. Global Veterinary Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 135. Global Veterinary Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. Global Veterinary Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 137. Global Real-Time PCR Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 138. Asia-Pacific Real-Time PCR Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 139. Asia-Pacific Real-Time PCR Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 140. Asia-Pacific Real-Time PCR Devices Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 141. Asia-Pacific Real-Time PCR Devices Market Size, by Reagents Kits, 2017-2032 (USD Million)
TABLE 142. Asia-Pacific Real-Time PCR Devices Market Size, by Software And Services, 2017-2032 (USD Million)
TABLE 143. Asia-Pacific Real-Time PCR Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 144. Asia-Pacific Real-Time PCR Devices Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 145. Asia-Pacific Real-Time PCR Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 146. Asia-Pacific Real-Time PCR Devices Market Size, by Disease Diagnostics, 2017-2032 (USD Million)
TABLE 147. Asia-Pacific Real-Time PCR Devices Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 148. Asia-Pacific Real-Time PCR Devices Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 149. Asia-Pacific Real-Time PCR Devices Market Size, by Oncology Diagnostics, 2017-2032 (USD Million)
TABLE 150. Asia-Pacific Real-Time PCR Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 151. North America Real-Time PCR Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 152. North America Real-Time PCR Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 153. North America Real-Time PCR Devices Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 154. North America Real-Time PCR Devices Market Size, by Reagents Kits, 2017-2032 (USD Million)
TABLE 155. North America Real-Time PCR Devices Market Size, by Software And Services, 2017-2032 (USD Million)
TABLE 156. North America Real-Time PCR Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 157. North America Real-Time PCR Devices Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 158. North America Real-Time PCR Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 159. North America Real-Time PCR Devices Market Size, by Disease Diagnostics, 2017-2032 (USD Million)
TABLE 160. North America Real-Time PCR Devices Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 161. North America Real-Time PCR Devices Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 162. North America Real-Time PCR Devices Market Size, by Oncology Diagnostics, 2017-2032 (USD Million)
TABLE 163. North America Real-Time PCR Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 164. Latin America Real-Time PCR Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 165. Latin America Real-Time PCR Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 166. Latin America Real-Time PCR Devices Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 167. Latin America Real-Time PCR Devices Market Size, by Reagents Kits, 2017-2032 (USD Million)
TABLE 168. Latin America Real-Time PCR Devices Market Size, by Software And Services, 2017-2032 (USD Million)
TABLE 169. Latin America Real-Time PCR Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 170. Latin America Real-Time PCR Devices Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 171. Latin America Real-Time PCR Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 172. Latin America Real-Time PCR Devices Market Size, by Disease Diagnostics, 2017-2032 (USD Million)
TABLE 173. Latin America Real-Time PCR Devices Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 174. Latin America Real-Time PCR Devices Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 175. Latin America Real-Time PCR Devices Market Size, by Oncology Diagnostics, 2017-2032 (USD Million)
TABLE 176. Latin America Real-Time PCR Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 177. Europe Real-Time PCR Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 178. Europe Real-Time PCR Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 179. Europe Real-Time PCR Devices Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 180. Europe Real-Time PCR Devices Market Size, by Reagents Kits, 2017-2032 (USD Million)
TABLE 181. Europe Real-Time PCR Devices Market Size, by Software And Services, 2017-2032 (USD Million)
TABLE 182. Europe Real-Time PCR Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 183. Europe Real-Time PCR Devices Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 184. Europe Real-Time PCR Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 185. Europe Real-Time PCR Devices Market Size, by Disease Diagnostics, 2017-2032 (USD Million)
TABLE 186. Europe Real-Time PCR Devices Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 187. Europe Real-Time PCR Devices Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 188. Europe Real-Time PCR Devices Market Size, by Oncology Diagnostics, 2017-2032 (USD Million)
TABLE 189. Europe Real-Time PCR Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 190. Middle East Real-Time PCR Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 191. Middle East Real-Time PCR Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 192. Middle East Real-Time PCR Devices Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 193. Middle East Real-Time PCR Devices Market Size, by Reagents Kits, 2017-2032 (USD Million)
TABLE 194. Middle East Real-Time PCR Devices Market Size, by Software And Services, 2017-2032 (USD Million)
TABLE 195. Middle East Real-Time PCR Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 196. Middle East Real-Time PCR Devices Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 197. Middle East Real-Time PCR Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 198. Middle East Real-Time PCR Devices Market Size, by Disease Diagnostics, 2017-2032 (USD Million)
TABLE 199. Middle East Real-Time PCR Devices Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 200. Middle East Real-Time PCR Devices Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 201. Middle East Real-Time PCR Devices Market Size, by Oncology Diagnostics, 2017-2032 (USD Million)
TABLE 202. Middle East Real-Time PCR Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 203. Africa Real-Time PCR Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 204. Africa Real-Time PCR Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 205. Africa Real-Time PCR Devices Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 206. Africa Real-Time PCR Devices Market Size, by Reagents Kits, 2017-2032 (USD Million)
TABLE 207. Africa Real-Time PCR Devices Market Size, by Software And Services, 2017-2032 (USD Million)
TABLE 208. Africa Real-Time PCR Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 209. Africa Real-Time PCR Devices Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 210. Africa Real-Time PCR Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 211. Africa Real-Time PCR Devices Market Size, by Disease Diagnostics, 2017-2032 (USD Million)
TABLE 212. Africa Real-Time PCR Devices Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 213. Africa Real-Time PCR Devices Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 214. Africa Real-Time PCR Devices Market Size, by Oncology Diagnostics, 2017-2032 (USD Million)
TABLE 215. Africa Real-Time PCR Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 216. Global Real-Time PCR Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 217. ASEAN Real-Time PCR Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 218. ASEAN Real-Time PCR Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 219. ASEAN Real-Time PCR Devices Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 220. ASEAN Real-Time PCR Devices Market Size, by Reagents Kits, 2017-2032 (USD Million)
TABLE 221. ASEAN Real-Time PCR Devices Market Size, by Software And Services, 2017-2032 (USD Million)
TABLE 222. ASEAN Real-Time PCR Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 223. ASEAN Real-Time PCR Devices Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 224. ASEAN Real-Time PCR Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 225. ASEAN Real-Time PCR Devices Market Size, by Disease Diagnostics, 2017-2032 (USD Million)
TABLE 226. ASEAN Real-Time PCR Devices Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 227. ASEAN Real-Time PCR Devices Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 228. ASEAN Real-Time PCR Devices Market Size, by Oncology Diagnostics, 2017-2032 (USD Million)
TABLE 229. ASEAN Real-Time PCR Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 230. GCC Real-Time PCR Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 231. GCC Real-Time PCR Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 232. GCC Real-Time PCR Devices Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 233. GCC Real-Time PCR Devices Market Size, by Reagents Kits, 2017-2032 (USD Million)
TABLE 234. GCC Real-Time PCR Devices Market Size, by Software And Services, 2017-2032 (USD Million)
TABLE 235. GCC Real-Time PCR Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 236. GCC Real-Time PCR Devices Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 237. GCC Real-Time PCR Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 238. GCC Real-Time PCR Devices Market Size, by Disease Diagnostics, 2017-2032 (USD Million)
TABLE 239. GCC Real-Time PCR Devices Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 240. GCC Real-Time PCR Devices Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 241. GCC Real-Time PCR Devices Market Size, by Oncology Diagnostics, 2017-2032 (USD Million)
TABLE 242. GCC Real-Time PCR Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 243. European Union Real-Time PCR Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 244. European Union Real-Time PCR Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 245. European Union Real-Time PCR Devices Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 246. European Union Real-Time PCR Devices Market Size, by Reagents Kits, 2017-2032 (USD Million)
TABLE 247. European Union Real-Time PCR Devices Market Size, by Software And Services, 2017-2032 (USD Million)
TABLE 248. European Union Real-Time PCR Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 249. European Union Real-Time PCR Devices Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 250. European Union Real-Time PCR Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 251. European Union Real-Time PCR Devices Market Size, by Disease Diagnostics, 2017-2032 (USD Million)
TABLE 252. European Union Real-Time PCR Devices Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 253. European Union Real-Time PCR Devices Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 254. European Union Real-Time PCR Devices Market Size, by Oncology Diagnostics, 2017-2032 (USD Million)
TABLE 255. European Union Real-Time PCR Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 256. BRICS Real-Time PCR Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 257. BRICS Real-Time PCR Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 258. BRICS Real-Time PCR Devices Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 259. BRICS Real-Time PCR Devices Market Size, by Reagents Kits, 2017-2032 (USD Million)
TABLE 260. BRICS Real-Time PCR Devices Market Size, by Software And Services, 2017-2032 (USD Million)
TABLE 261. BRICS Real-Time PCR Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 262. BRICS Real-Time PCR Devices Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 263. BRICS Real-Time PCR Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 264. BRICS Real-Time PCR Devices Market Size, by Disease Diagnostics, 2017-2032 (USD Million)
TABLE 265. BRICS Real-Time PCR Devices Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 266. BRICS Real-Time PCR Devices Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 267. BRICS Real-Time PCR Devices Market Size, by Oncology Diagnostics, 2017-2032 (USD Million)
TABLE 268. BRICS Real-Time PCR Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 269. G7 Real-Time PCR Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 270. G7 Real-Time PCR Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 271. G7 Real-Time PCR Devices Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 272. G7 Real-Time PCR Devices Market Size, by Reagents Kits, 2017-2032 (USD Million)
TABLE 273. G7 Real-Time PCR Devices Market Size, by Software And Services, 2017-2032 (USD Million)
TABLE 274. G7 Real-Time PCR Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 275. G7 Real-Time PCR Devices Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 276. G7 Real-Time PCR Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 277. G7 Real-Time PCR Devices Market Size, by Disease Diagnostics, 2017-2032 (USD Million)
TABLE 278. G7 Real-Time PCR Devices Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 279. G7 Real-Time PCR Devices Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 280. G7 Real-Time PCR Devices Market Size, by Oncology Diagnostics, 2017-2032 (USD Million)
TABLE 281. G7 Real-Time PCR Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 282. NATO Real-Time PCR Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 283. NATO Real-Time PCR Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 284. NATO Real-Time PCR Devices Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 285. NATO Real-Time PCR Devices Market Size, by Reagents Kits, 2017-2032 (USD Million)
TABLE 286. NATO Real-Time PCR Devices Market Size, by Software And Services, 2017-2032 (USD Million)
TABLE 287. NATO Real-Time PCR Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 288. NATO Real-Time PCR Devices Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 289. NATO Real-Time PCR Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 290. NATO Real-Time PCR Devices Market Size, by Disease Diagnostics, 2017-2032 (USD Million)
TABLE 291. NATO Real-Time PCR Devices Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 292. NATO Real-Time PCR Devices Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 293. NATO Real-Time PCR Devices Market Size, by Oncology Diagnostics, 2017-2032 (USD Million)
TABLE 294. NATO Real-Time PCR Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 295. Global Real-Time PCR Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 296. United States Real-Time PCR Devices Market Size, 2017-2032 (USD Million)
TABLE 297. United States Real-Time PCR Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 298. United States Real-Time PCR Devices Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 299. United States Real-Time PCR Devices Market Size, by Reagents Kits, 2017-2032 (USD Million)
TABLE 300. United States Real-Time PCR Devices Market Size, by Software And Services, 2017-2032 (USD Million)
TABLE 301. United States Real-Time PCR Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 302. United States Real-Time PCR Devices Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 303. United States Real-Time PCR Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 304. United States Real-Time PCR Devices Market Size, by Disease Diagnostics, 2017-2032 (USD Million)
TABLE 305. United States Real-Time PCR Devices Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 306. United States Real-Time PCR Devices Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 307. United States Real-Time PCR Devices Market Size, by Oncology Diagnostics, 2017-2032 (USD Million)
TABLE 308. United States Real-Time PCR Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 309. Canada Real-Time PCR Devices Market Size, 2017-2032 (USD Million)
TABLE 310. Canada Real-Time PCR Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 311. Canada Real-Time PCR Devices Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 312. Canada Real-Time PCR Devices Market Size, by Reagents Kits, 2017-2032 (USD Million)
TABLE 313. Canada Real-Time PCR Devices Market Size, by Software And Services, 2017-2032 (USD Million)
TABLE 314. Canada Real-Time PCR Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 315. Canada Real-Time PCR Devices Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 316. Canada Real-Time PCR Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 317. Canada Real-Time PCR Devices Market Size, by Disease Diagnostics, 2017-2032 (USD Million)
TABLE 318. Canada Real-Time PCR Devices Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 319. Canada Real-Time PCR Devices Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 320. Canada Real-Time PCR Devices Market Size, by Oncology Diagnostics, 2017-2032 (USD Million)
TABLE 321. Canada Real-Time PCR Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 322. Mexico Real-Time PCR Devices Market Size, 2017-2032 (USD Million)
TABLE 323. Mexico Real-Time PCR Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 324. Mexico Real-Time PCR Devices Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 325. Mexico Real-Time PCR Devices Market Size, by Reagents Kits, 2017-2032 (USD Million)
TABLE 326. Mexico Real-Time PCR Devices Market Size, by Software And Services, 2017-2032 (USD Million)
TABLE 327. Mexico Real-Time PCR Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 328. Mexico Real-Time PCR Devices Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 329. Mexico Real-Time PCR Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 330. Mexico Real-Time PCR Devices Market Size, by Disease Diagnostics, 2017-2032 (USD Million)
TABLE 331. Mexico Real-Time PCR Devices Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 332. Mexico Real-Time PCR Devices Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 333. Mexico Real-Time PCR Devices Market Size, by Oncology Diagnostics, 2017-2032 (USD Million)
TABLE 334. Mexico Real-Time PCR Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 335. Brazil Real-Time PCR Devices Market Size, 2017-2032 (USD Million)
TABLE 336. Brazil Real-Time PCR Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 337. Brazil Real-Time PCR Devices Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 338. Brazil Real-Time PCR Devices Market Size, by Reagents Kits, 2017-2032 (USD Million)
TABLE 339. Brazil Real-Time PCR Devices Market Size, by Software And Services, 2017-2032 (USD Million)
TABLE 340. Brazil Real-Time PCR Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 341. Brazil Real-Time PCR Devices Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 342. Brazil Real-Time PCR Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 343. Brazil Real-Time PCR Devices Market Size, by Disease Diagnostics, 2017-2032 (USD Million)
TABLE 344. Brazil Real-Time PCR Devices Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 345. Brazil Real-Time PCR Devices Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 346. Brazil Real-Time PCR Devices Market Size, by Oncology Diagnostics, 2017-2032 (USD Million)
TABLE 347. Brazil Real-Time PCR Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 348. United Kingdom Real-Time PCR Devices Market Size, 2017-2032 (USD Million)
TABLE 349. United Kingdom Real-Time PCR Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 350. United Kingdom Real-Time PCR Devices Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 351. United Kingdom Real-Time PCR Devices Market Size, by Reagents Kits, 2017-2032 (USD Million)
TABLE 352. United Kingdom Real-Time PCR Devices Market Size, by Software And Services, 2017-2032 (USD Million)
TABLE 353. United Kingdom Real-Time PCR Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 354. United Kingd

Companies Mentioned

  • Abcam plc
  • Agilent Technologies, Inc.
  • Analytik Jena AG
  • Becton Dickinson and Company
  • Bio Molecular Systems Pty Ltd.
  • Bio-Rad Laboratories, Inc.
  • BioFire Diagnostics, LLC
  • Eppendorf AG
  • Hologic, Inc.
  • Illumina, Inc.
  • Lumiprobe Corporation
  • Mesa Biotech, Inc.
  • Promega Corporation
  • Qiagen GmbH
  • QIAGEN N.V.
  • Roche Diagnostics International AG
  • SGI-DNA, LLC
  • Stilla Technologies SA
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.

Related Topics

Related Reports

Real-time PCR Market - Global Forecast 2026-2032 - Product Image

Real-time PCR Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Digital PCR & Real-Time PCR Market - Global Forecast 2026-2032 - Product Image

Digital PCR & Real-Time PCR Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Digital PCRs - Global Strategic Business Report - Product Image

Digital PCRs - Global Strategic Business Report

  • Report
  • 280 Pages
  • Global
From
Real-Time PCR, Digital PCR, and End-Point PCR Market Size, Share & Trends Analysis Report by Technology, Product, Application, Region, and Growth Forecasts, 2026-2033 - Product Image

Real-Time PCR, Digital PCR, and End-Point PCR Market Size, Share & Trends Analysis Report by Technology, Product, Application, Region, and Growth Forecasts, 2026-2033

  • Report
  • 120 Pages
  • Global
From
PCR Tests - Global Strategic Business Report - Product Image

PCR Tests - Global Strategic Business Report

  • Report
  • 479 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.